- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The pharmaceutical company reported better-than-expected results on Friday morning. Grab its ADRs now.
Pharma group Sanofi rises on improved guidance and RBS gains after a third-quarter profit beat.
Analysts are expecting to see a year-over-year decline in earnings and revenue when Sanofi (SNY) posts 2016 third-quarter results before Friday's market open.
Tech giants, Big Pharma and insurers are all angling to profit from the $3 trillion-plus U.S. healthcare market.